Please login to create your UC TechAlerts.
Request a new password for
Required
Find technologies available for licensing from UC Davis.
No technologies match these criteria. Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above
JC071ch, a Chimeric Monoclonal Antibody Specific for Canine PDL1
Please view this family of technologies HERE
JC071c4, a Caninized Monoclonal Antibody Mutant Specific for Canine PDL1 That Could Avoid Potential Nglycosylation within Light Chain CDR1
JC071c2, a Caninized Monoclonal Antibody Mutant Specific for Canine PDL1 That Could Avoid Potential Nglycosylation and W Oxidation
JC071c1, a Caninized Monoclonal Antibody Mutant Specific for Canine PDL1 That Could Avoid Potential Nglycosylation and N-deamidation within CDR Sequences
Jc071c, a Caninized Monoclonal Antibody Specific for Canine Pd-L1
Researchers at the University of California, Davis, have developed a modified, caninized monoclonal antibody that targets canine PD-L1, developed for use as dog cancer therapy.
Transabdominal Fetal Oximetry (TFO) for Intrapartum Fetal Health Monitoring
Researchers at the University of California, Davis have developed an innovative technology designed to directly measure fetus blood oxygen saturation level through the maternal abdomen from the onset of labor until birth, thereby improving fetal health outcomes.
A Novel Antibody Treatment of Drug-induced, Age- and Disease-Related Bone Loss
Researchers at the University of California, Davis have developed a technology that targets CD147 to significantly improve bone health and treat musculoskeletal diseases without the side effects of current therapies.
Rollover Prediction and Alert for All-Terrain Vehicle
Researchers at the University of California Davis have developed a system designed to predict and prevent ATV rollovers, enhancing rider safety.